Semax

Semax is a synthetic peptide derived from the adrenocorticotropic hormone (ACTH 4–10) fragment, modified to enhance stability and research applicability. In controlled laboratory environments, Semax has been studied for its interaction with neuropeptide signaling pathways, neurotrophic factor regulation, and central nervous system research models. Due to its molecular structure and receptor interaction profile, it remains a compound of interest in neuroscience and cognitive pathway investigations.

Preclinical studies have examined Semax for its influence on brain-derived neurotrophic factor (BDNF) expression research, neurotransmitter modulation pathways, and synaptic signaling mechanisms. Ongoing scientific evaluations continue to explore its cellular communication effects and molecular activity within experimental neurobiology frameworks. Its peptide stability and receptor-binding characteristics make it relevant in laboratory-based neurological research settings.

This research peptide is supplied in a 3ML vial and manufactured under strict laboratory-controlled standards. Each batch undergoes analytical verification to confirm molecular identity, purity, and structural integrity. Semax is intended strictly for laboratory research and analytical purposes only and is not for human consumption.